Short answer
LENSAR, Inc. (LNSR) filed its Q2 2026 10-Q quarterly report on Aug 13, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $15M (up 19.8% year over year) with net income of $4M.
Q2 2026 key financials · XBRL
- Revenue
- $15M
- +19.8% YoY · +25.3% QoQ
- Net income
- $4M
- +300.4% YoY · −90.3% QoQ
- Operating margin
- 14.5%
- EPS (diluted)
- $0.61
- +535.7% YoY
Source: XBRL data from the LENSAR, Inc. (LNSR) Q2 2026 10-Q on SEC EDGAR. USD.
LENSAR, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Terminated Alcon merger: shareholder demands and prior books-and-records litigation create potential damages and management distraction
- Regulatory clearance: ALLY System growth depends on additional approvals and certifications across target markets
- Market adoption: advanced cataract procedures typically lack third-party reimbursement, leaving patients responsible for incremental costs
- Customer concentration: one customer represented approximately 14% of six-month 2026 revenue
- Liquidity and financing: current resources expected to fund operations for at least one year, while $3.0 million cash must remain deposited under the credit agreement
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other LENSAR, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.